LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA
Go back to LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA| Moneylogix Group, Inc. (AMEX: LXG) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $0.01 | |||
| Open | $0.01 | 52 Week Low | $0.01 | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $-1.32 | |||
| Volume | 0 | |||||
| (AMEX: LXXGF) | Delayed: 0.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.08 | 52 Week High | $ | |||
| Open | $2.76 | 52 Week Low | $ | |||
| Day High | $0.08 | P/E | N/A | |||
| Day Low | $0.08 | EPS | $ | |||
| Volume | 57,673 | |||||
